Daniel Paul McTavish

Title: The Innovations of Daniel Paul McTavish

Introduction

Daniel Paul McTavish is an accomplished inventor based in Fridley, MN (US). He has made significant contributions to the field of biocompatible prosthetics. His innovative work focuses on enhancing the safety and effectiveness of prosthetic tissues.

Latest Patents

McTavish holds a patent for a biocompatible prosthetic tissue. This patent involves a process where crosslinked tissue is treated with one or more toxicity-reducing solutions to eliminate cytotoxicity associated with the crosslinking process. The method includes contacting the crosslinked tissue with an inorganic sulfur-oxygen group to form chemical adducts of aldehydes and the inorganic sulfur-oxygen group. The resulting cytotoxicity-reduced crosslinked tissue is designed to have no residual cytotoxicity. In preferred embodiments, multiple toxicity-reducing agents are utilized to detoxify the tissue, including inorganic sulfur-oxygen ions, organic sulfates, amines, ammonia/ammonium, and surfactants.

Career Highlights

McTavish is currently associated with St. Jude Medical, Inc., where he continues to innovate in the field of medical devices. His work has been instrumental in advancing the technology used in prosthetics, making them safer for patients.

Collaborations

Throughout his career, McTavish has collaborated with notable colleagues, including Paul Edward Ashworth and Matthew Frank Ogle. These partnerships have contributed to the development of groundbreaking technologies in the medical field.

Conclusion

Daniel Paul McTavish's contributions to biocompatible prosthetic tissue represent a significant advancement in medical technology. His innovative approaches to reducing cytotoxicity in prosthetics are paving the way for safer and more effective medical solutions.